Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity

NHS England · Awarded

Buyer
NHS England
Status
Awarded
Country
United Kingdom
Region
EU - Western Europe
Sector
Manufacturing
Reference
UK-CFA-ocds-b5fd17-63bc49a4-6875-44ee-bcf1-d9ea348f4445
Published
2026-03-12
Deadline
2026-03-12

Tender summary

EONIS-Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 4 Screening laboratories, with the addition of the ISE for Spinal Muscular Atrophy (SMA).

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap